This map shows the geographic impact of Simpson Gm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simpson Gm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simpson Gm more than expected).
This network shows the impact of papers produced by Simpson Gm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simpson Gm. The network helps show where Simpson Gm may publish in the future.
Co-authorship network of co-authors of Simpson Gm
This figure shows the co-authorship network connecting the top 25 collaborators of Simpson Gm.
A scholar is included among the top collaborators of Simpson Gm based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Simpson Gm. Simpson Gm is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Gm, Simpson, et al.. (1988). Plasma levels and therapeutic response with trimipramine treatment of endogenous depression.. PubMed. 49(3). 113–6.10 indexed citations
2.
Elia, Josephine, et al.. (1987). Teratogenicity of psychotherapeutic medications.. PubMed. 23(4). 531–86.32 indexed citations
Gm, Simpson. (1984). A brief history of depot neuroleptics.. PubMed. 45(5 Pt 2). 3–4.23 indexed citations
5.
Gm, Simpson, et al.. (1978). Baclofen in the treatment of tardive dyskinesia and schizophrenia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(2). 16–8.22 indexed citations
6.
Gm, Simpson, et al.. (1977). The treatment of tardive dyskinesia.. PubMed. 17. 235–45.2 indexed citations
7.
Gm, Simpson, et al.. (1975). Plasma/blood level monitoring techniques in psychiatry.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(4). 18–20.5 indexed citations
8.
Gm, Simpson, et al.. (1975). A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector.. PubMed. 1(4). 445–54.31 indexed citations
9.
Gm, Simpson, et al.. (1974). An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.. PubMed. 16(5). 477–82.1 indexed citations
10.
Gm, Simpson, et al.. (1968). Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.. PubMed. 10(10). 520–8.1 indexed citations
11.
Gm, Simpson, et al.. (1968). A study of intramuscular thiothixene in acute schizophrenia.. PubMed. 10(9). 448–52.1 indexed citations
12.
Gm, Simpson, et al.. (1967). A preliminary study of prothipendyl in chronic schizophrenia.. PubMed. 9(5). 265–8.2 indexed citations
13.
Gm, Simpson, et al.. (1967). A controlled study of haloperidol in chronic schizophrenia.. PubMed. 9(8). 407–12.15 indexed citations
14.
Gm, Simpson, et al.. (1966). A PRELIMINARY STUDY OF P-5227, a new active tricyclic antipsychotic agent.. PubMed. 8(10). 465–71.3 indexed citations
15.
Gm, Simpson, et al.. (1966). A preliminary study of trimiprimine in chronic schizophrenia.. PubMed. 8(5). 225–31.5 indexed citations
16.
Gm, Simpson, et al.. (1966). The effect of phenothiazines on cerebrospinal fluid.. PubMed. 2(3). 223–6.4 indexed citations
17.
Gm, Simpson, et al.. (1966). A preliminary study of SKF-14,336 in chronic schizophrenia.. PubMed. 8(9). 447–51.4 indexed citations
18.
Gm, Simpson, et al.. (1965). USE OF SODIUM DIPHENYLHYDANTOIN IN TREATMENT OF LEG ULCERS.. PubMed. 65. 886–8.23 indexed citations
19.
Gm, Simpson, et al.. (1963). Diagnostic limitations of Achilles tendon reflex in thyroid disease.. PubMed. 63. 1148–53.9 indexed citations
20.
Gm, Simpson, et al.. (1962). Enovid in the treatment of psychic disturbances associated with menstruation.. PubMed. 23. 589–90.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.